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Available online 29 December 2015Flavonoid bioavailability has attracted a lot of attention over the last decade due to the increasing evidence of
their health-promoting properties. However, conﬂicting results appear in the literature, especially on the bio-
availability of ﬂavonoid glycosides in vitro versus in vivo. In in vitro studies, where Caco-2 cells are usually
used, hydrophobic aglycones have been reported to bemore bioavailable. On the contrary, in vivo studies suggest
that increasing the aqueous solubility ofﬂavonoids favors their bioavailability. In this paper,we aim to ﬁll this gap
by analyzing the role of the gastrointestinal mucus on ﬂavonoid bioavailability. Mucus is a complex viscoelastic
barrier that serves as the ﬁrst line of defense against pathogens, particles and several toxins, while allowing
nutrients to penetrate through and reach the epithelia. A mechanism by which mucus participates in ﬂavonoid
absorption is proposed. Also, the effect ofﬂavonoids on the biophysical properties of themucus layer is discussed.
This article therefore reviews the complex interaction between ﬂavonoids and mucus for the ﬁrst time.
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Macrorheology1. Introduction
Flavonoids are the most widely spread and diverse group of
polyphenols. There are more than 8000 different ﬂavonoids identiﬁed
and some of the most abundant are quercetin and kaempferol, which
often occur as complex conjugates with glycosides (commonly glucose,
galactose and rhamnose) and acyl groups in nature (Fiol et al., 2012;
Francisco et al., 2009; Olsen, Aaby, & Borge, 2010). Flavonoids consist
of two aromatic rings and one heterocyclic ring containing an oxygen
atom. Different classes of ﬂavonoids then arise depending on the
relative position of different functional groups in the 15-carbon skeleton
(Schmidt et al., 2010). Recently, high regardhas beenplaced on theseme-
tabolites due to their biological activity, which includes angiotensin-
converting enzyme inhibitory activity (Actis-Goretta, Ottaviani, & Fraga,
2005; Balasuriya & Rupasinghe, 2012), several mechanisms against
obesity (Hsu & Yen, 2008), and most popularly, antioxidant activity
(Fiol et al., 2012; Pietta, 2000), among others.
Much research has been done to demonstrate the bioavailability of
ﬂavonoids following ingestion and the several barriers that hinder
their intestinal absorption (Gonzales et al., in press; Manach,
Williamson, Morand, Scalbert, & Rémésy, 2005). There are currently
conﬂicting results derived from both in vitro and in vivo reports on
the fate and efﬁciency of intestinal absorption of different ﬂavonoid).forms. For instance, while in vitro results point to the higher bioavail-
ability of ﬂavonoid aglycones, some in vivo experiments reported
higher levels of ﬂavonoid metabolites upon ingestion of ﬂavonoid
glucosides.
Certain gaps in our knowledge on the bioavailability of ﬂavonoids
and other phytochemicals have been reviewed (Bohn et al., 2015). For
instance, the involvement of the mucus layer in most ﬂavonoid
digestion and bioavailability studies remains largely unexplained in
current literature. In this review, we aim to examine the interaction of
ﬂavonoids and gastrointestinal mucus, and its potential to alter ﬂavo-
noid bioavailability and mucosal biophysical properties. A mechanistic
view on the role of intestinal mucus on ﬂavonoid absorption is thereby
proposed along with some future perspectives.2. Mucus
Mucus is a highly complex viscoelastic secretion that covers epithe-
lial surfaces, such as respiratory, ocular, reproductive and gastrointesti-
nal (GI). In the GI tract, the mucus layer is the ﬁrst line of protection
against infection and intoxication, but also serves as a selective barrier
to allow nutrients to diffuse to the epithelial layer. This selectivity is
most important in the small intestine, where most of the nutrient
absorption takes place and the mucus layer is thinnest. However, the
rules governing this selective barrier function remain unclear (Lai,
Wang, Wirtz, & Hanes, 2009; Macierzanka et al., 2014).
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(1–2%), proteins (growth factors, lysozyme, immunoglobulins, etc),
cellular debris, DNA (around 0.02%) and mucin, which is primarily
responsible for its viscoelastic properties (Bansil & Turner, 2006; Lai
et al., 2009). Although, extracellular DNA content in mucus has also
been shown to increase its microrheology and barrier properties
(Macierzanka et al., 2014). In the human GI tract, the mucus layer is
thickest in the stomach (50–450 μm) and colon (110–160 μm), while
the thickness in the small intestines varies depending on the diet and
other digestive activities (Cone, 2009). Mucus of the GI tract is
composed of both membrane-bound and secreted mucins, of which
more than 20 are known, including MUC5AC and MUC2 that are
secreted in the stomach and intestines, respectively (Ensign, Cone, &
Hanes, 2012; Mackie, Round, Rigby, & Macierzanka, 2012). Mucins are
large glycoproteins of 0.5–20 MDa in weight comprising of ~80%
oligosaccharides that are attached to the protein core via O-glycosidic
bonding to serine and threonine hydroxyl side chains, resembling a bot-
tle brush-like structure (Bansil & Turner, 2006). Uponmucin secretion, a
dense unstirred layer of mucus is rapidly built above the epithelial cells.
Far from the epithelia, the mucus expands by proteolytic expansion
causing it to loosen. In this loose layer, commensal microbes could
thrive while the inner more dense mucus layer is thought to be largely
impenetrable to bacteria in healthy conditions (Johansson et al., 2013;
Malin E. V. Johansson et al., 2008).
The strength of interaction of mucin monomers, their degree of
entanglement and the size of the pores in the network dictate the
relative strength of the formed viscoelastic gel, which is characterized
by its dynamic and shear-thinning properties (Ensign et al., 2012;
Mackie et al., 2012). These properties givemucus the ability tomaintain
the dense unstirred layer on the epithelium despite the vigorous
shearing in the intestinal lumen caused by peristalsis (Cone, 2009). To
protect the epithelium, a rapid turnover of this layer occurs by continu-
ous secretion of mucus, replacing both the tightly and loosely adherent
layers. Particles and nutrientsmust thereforemigrate upstream to reach
the epithelium. Hence, a rapid and efﬁcient diffusion of molecules, such
as polyphenols, is a prerequisite to intestinal uptake. For a deeper
discussion on mucus structure and properties, we recommend the
reviews of Bansil, Stanley, and Lamont (1995); Cone (2009); Lai et al.
(2009) and Mackie et al. (2012).
3. Emulsiﬁcation increases ﬂavonoid bioavailability: potential role
of intestinal mucus in ﬂavonoid absorption regulation
The low bioavailability of ﬂavonoids remains a hurdle to their appli-
cability as potent bioactive molecules. Thus, numerous studies have
beenmade to understand themechanisms of absorption aswell as tech-
niques to increase the intestinal absorption of ﬂavonoids. Cellular
models such as Caco-2 cells have been extensively used to simulate
the intestinal permeability of ﬂavonoids (Barrington et al., 2009;
Tammela et al., 2004; Tian, Yang, Yang, & Wang, 2009). Results from
these experiments revealed that membrane permeability is of great im-
portance for ﬂavonoid transport since passive diffusion is the dominant
absorption route and thus, the hydrophobicity of the molecule plays a
crucial role in intestinal absorption (Barrington et al., 2009; Gonzales
et al., 2015; Liu & Hu, 2002; Tammela et al., 2004; Tian et al., 2009).
Therefore, ﬂavonoid glycosides are generally poorly absorbed through
the intestinal cells/walls due to their hydrophilicity, thus reducing
membrane permeability (Dai, Yang, & Li, 2008), unless highly actively
transported. The involvement of active transporters in the transport of
ﬂavonoid glycosides still remains under debate and more research is
needed to understand this mechanism.
Interestingly, animal and human studies suggest that certain ﬂavo-
noid glucosides are absorbed more efﬁciently than their aglycone
forms. In a feeding study in humans, it was found that quercetin
glucoside is absorbed more than quercetin aglycone (Hollman, de
Vries, van Leeuwen, Mengelers, & Katan, 1995; Hollman et al., 1997;Morand, Manach, Crespy, & Remesy, 2000b). The same observation
was obtained from feeding studies using pigs (Cermak, Landgraf, &
Wolffram, 2003), rats (Morand, Manach, Crespy, & Remesy, 2000a),
and dogs (Reinboth, Wolffram, Abraham, Ungemach, & Cermak,
2010). While several hypotheses have been formulated, such as effec-
tive deglucosylation by bacteria or brush border enzymes of the epithe-
lial cells, current literature has failed to provide a concrete explanation
of this inconsistency. Cermak et al. (2003) hypothesized that the hydro-
philic quercetin glucoside may have concentrated at the brush border,
where deglucosylation occurs. This implies that the glucoside may
have been able to penetrate through the mucus layer intact.
Flavonoid aglycones and glycosides belong to class II (low solubility
and high permeability) and class IV (low solubility and low permeabil-
ity) according to the biopharmaceutical classiﬁcation system (BCS).
Therefore, strategies to enhance the absorption of ﬂavonoids include in-
creasing their aqueous solubility (Kaur & Kaur, 2014). Permeability is
not an issue for glycosides since active deglycosylation occurs in the
brush border by β-glucosidases (lactase-phlorizin hydrolase), releasing
a highly permeable aglycone (Day et al., 1998; Németh et al., 2003).
Hence, attempts to increase the bioavailability of ﬂavonoids generally
involved methods to increase their aqueous solubility, such as micro-
and nano-emulsions, andmacromolecule complexation. Brieﬂy, several
techniques to increase bioavailability include incorporation of ﬂavo-
noids to borneol/methanol eutectic mixtures, micro-emulsions, polyvi-
nylpyrrolidone dispersion, lecithin complexation, and cyclodextrin
complexation (Thilakarathna & Rupasinghe, 2013). The formulation of
ﬂavonoid aglycones into nanocrystals has also been previously
described as an effective way of improving bioavailability (Li et al.,
2013). All of these methods increase aqueous solubility of the ﬂavonoid
aglycone. However, the mechanisms of absorption enhancement
remain unclear (Shen, Li, Li, & Zhao, 2011).
Dietary factors have also been shown to greatly improve the bio-
availability of ﬂavonoid aglycones. For instance, it has been shown
that dietary fat increases the bioavailability of quercetin aglycones
(Azuma, Ippoushi, Ito, Higashio, & Terao, 2002; Guo et al., 2013;
Lesser, Cermak, & Wolffram, 2004). These reports attributed the en-
hanced bioavailability of the aglycone to its incorporation into mixed
micelles, which permitted its diffusion through the unstirred mucus
layer.
Given these ﬁndings, it is apparent thatwhile hydrophobic ﬂavonoid
aglycones are favorably absorbed by intestinal cells, glycosylation and
increasing aqueous solubility increase overall intestinal absorption. A
logical mechanism therefore is the possible involvement of the mucus
layer, which only allows the penetration of hydrophilic compounds
(ﬂavonoid glycosides or hydrophilic ﬂavonoid complexes) and that
deglycosylation occurs after the compound has penetrated through
the mucus releasing the aglycone, which could then passively diffuse
through the cell membrane. This hypothesis could be summarized in
Fig. 1.
Hydrophobic ﬂavonoid aglycones that reach the small intestines are
unable to penetrate through themucus layer and are thus pushed to the
large intestines via peristalsis and are thenmetabolized (i.e. into smaller
phenolic acid derivatives) by intestinal bacteria. However, in the
presence of dietary fat and bile, micelles form and serve as carriers of
aglycones through themucus layer. They are then releasedupon contact
with the brush border where passive diffusion is likely to occur through
the cells. Soluble ﬂavonoid glycosides on the other hand, are able to
penetrate through the mucus layer to reach the epithelium. Upon
contact with the brush border, β-glucosidases such as the lactase-
phlorizin hydrolase (LPH) cleave-off the glucose moiety to release the
aglycone, which could then passively diffuse through the cells. Since in-
testinal cells are unable to produce rhamnosidases,ﬂavonoid containing
rhamnose moieties, such as rutin (quercetin-3-rutinoside) and hesper-
idin (hesperetin-7-rutinoside), remain intact in the small intestines and
are thus pushed to the large intestines,where fermentation by intestinal
bacteria occurs or the action of secreted bacterial rhamnosidases
Fig. 1. Proposed mechanism on the role of the mucus layer on the bioavailability of ﬂavonoid aglycone, ﬂavonoid glycoside, ﬂavonoid in micelles (or other complexes such as
nanoparticles), and ﬂavonoid glycorhamnosides.
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end, the aglycones that were released on the brush borders, or smaller
phenolic acid derivatives that were produced after bacterial metabolism
both in the small and large intestines, reach the epithelia, where phase I
metabolism and phase II metabolism take place. It must be noted howev-
er thatwhile bacteria also exist in the small intestines, the rate ofmucosal
diffusion (Gonzales et al., 2015) and intestinal uptake at that stage occurs
rapidly and thus the effect of duodenal bacteria is not as pronounced as in
the colon, where the absorption is slower and longer. The role of intesti-
nal bacteria on the metabolism of ﬂavonoids has been reviewed several
times in literature andwill not be discussed in this paper. Readers are ad-
vised to refer to Kimet al. (1998) for further detail. This proposedhypoth-
esis may explain the delayed occurrence of rutin and hesperidin
metabolites in plasma and the higher bioavailability of glucosides com-
pared with aglycones under low fat diet, and the increase in ﬂavonoid
bioavailability in high fat diet (Lesser et al., 2004).
An adaptation to the BCS for nutraceuticals has been developed by
the group of McClements, the nutraceutical bioavailability classiﬁcation
scheme (NuBACS) (McClements, Li, & Xiao, 2015). Brieﬂy, various
barriers to nutraceutical bioavailability are recognized during three
different classes, namely: bioaccessibility (B*), absorption (A*), andTable 1
The nutraceutical bioavailability classiﬁcation scheme (NuBACS) for characterizing nutraceutic
Class Sub-class
Bioaccessibility (B*) L: liberation
S: solubilization
I: interactions
Absorption (A*) ML: mucus layer
TJ: tight junction transport
BP: bilayer permeability
AT: active transporters
ET: efﬂux transporters
Transformation (T*) C: chemical degradation
M: metabolism
(−) denotes a barrier to bioavailability, (+) not a barrier, (?) still unresolved in literature, blank
may vary depending on the exact chemical structure of the ﬂavonoid in question.transformation (T*). Several factors that affect the bioavailability of
nutraceuticals in these classes are speciﬁed, as listed in Table 1. A (−)
sign signiﬁes that this particular factor affects the bioavailability of the
nutraceutical, whereas a (+) sign means that this class does not pose
a signiﬁcant hindrance to bioavailability. Most importantly, in this
scheme, McClements et al. (2015) stressed the underappreciated role
of the mucus layer as a limiting factor to the bioavailability of
nutraceuticals. Using this scheme, we propose ﬂavonoid aglycones to
be classiﬁed as B*(−)A*(−)ML,ETT*(−). On the other hand, soluble
ﬂavonoid glycosides are classiﬁed as B*(+)A*(−)BP,ETT*(−). The con-
trast between mucus layer permeability and the bilayer permeability
is clear. However, as already discussed, it must be noted that ﬂavonoid
glycosides are released as aglycones upon action of LPH. The importance
of themucus layer on ﬂavonoid bioavailability is thus givenmore recog-
nition. For details of this classiﬁcation scheme, readers are advised to
read McClements et al. (2015) and McClements (2015).
4. Effect of ﬂavonoids on mucus macrorheology
Thephysical properties of gels or ﬂuids are typically described by the
extent towhich the gel resists the tendency to ﬂow (viscousmodulus, Gal bioavailability (McClements et al., 2015).
Flavonoid aglycone Flavonoid glycoside (soluble)
− +
− +
− +
− +
+ −
+ ?
− −
− −
− −
spacesmean insufﬁcient data in the literature to support thismechanism. The classiﬁcation
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being deformed due to high strain (elastic modulus, G′) (Lai et al.,
2009). Based on oscillatory rheological measurements, mucus and
puriﬁed mucins show characteristics of a viscoelastic ﬂuid. That is,
when sheared it partially ﬂows and partially recovers its shape i.e. it
shows both elastic and viscous behaviors (Lai et al., 2009;
Macierzanka et al., 2011; Macierzanka et al., 2014). In our previous
work, we found that the bulk rheology of mucus and puriﬁed mucin is
not signiﬁcantly affected by ﬂavonoid glycosides or epigallocatechin
(EGCG), which is the most studied ﬂavonoid in terms of mucus
interaction (Fig. 2).
At this scale, the bulk rheology of mucus is so high that one might
think particles could not penetrate through it. Nonetheless, the penetra-
tion of nutrients, nanoparticles and other intestinal components proves
that bulk rheology alone is inadequate to explain the barrier properties
of mucus and that shorter lengthscale measurements are required (Lai
et al., 2009).5. Effect of ﬂavonoids on mucus microrheology
Mucus is not homogenous and so entities of much smaller scales
such as micro- and nano-particles are faced with a more localized envi-
ronment, which necessitates a different approach than measuring the
bulk rheology. In macrorheological measurements, the objective is to
understand the relationship between deformation rate and bulk
material stress. However, instead of these bulk physical properties, the
movement of nanoparticles through a heterogeneous matrix, such as
mucus, is inﬂuenced by the local environment, which is composed of
ﬂuids within the biopolymer network and the network mesh itself.
Thus, the viscoelasticity that is encountered bymicro- andnanoparticles
is termed “microrheology” (Lai et al., 2009; Zia & Brady, 2012). To ana-
lyzemicrorheology, theBrownianmovement of probe particles (b3 μm)
is trackedover timeusing confocalmicroscopy to determine the proper-
ties of the surrounding medium, hence called “particle tracking
microrheology” (PTM). At a scale of b3 μm, particles experience
Brownian motion and move randomly through space and on average
gradually increases its distance from its starting point. This is known
as the mean square displacement (MSD) of the particle and is recorded
over time (Δt). The MSD is then used to calculate the diffusion coefﬁ-
cient (D), wherein D =MSD/4Δt. Using the Stokes–Einstein equation,Fig. 2. Bulk rheological measurements on the effect of kaempferol glycosides (KG) (Gonzales
viscosity) and puriﬁed gastric mucin (B.1— G′ and G″, B.2 — viscosity) (unpublished data).the apparent microviscosity (η) of the mucus could be derived using
the equation:
η ¼ 2 kB T t
3 п abMSDN
ð1Þ
where kB is the Boltzmann constant, T is the temperature, and a is the
radius of the probe particle. For details on the principle of
microrheology in complex ﬂuids, readers are directed to the review of
Wirtz (2009).
The microrheology of GI mucus was found to be comparable to that
of partially puriﬁed mucins (3–3.4 mPa s) using 500 nm particle probes
coated with bile salts, which is approximately 103–104 times more
viscous than water. In this study, it was also found that adsorption of
bile salts to particles allows their penetration to the mucus layer. This
was attributed to the ability of bile salts to impart a negative charge
onto the particles thus allowing them to penetrate through a naturally
negatively charged mucus layer (Macierzanka et al., 2011).
Among many polyphenols, the ﬂavonoids from tea, speciﬁcally
epigallocatechin gallate (EGCG), have attracted interest in studying
ﬂavonoid–mucus interaction. In fact, most of the studies published so
far have used EGCG, and data for other ﬂavonoid species have not
been reported until recently. Also, these studies used puriﬁed mucins
and not the crude ex vivo mucus, which behaves differently. For
instance, Davies et al. (2014) demonstrated that EGCG increase the
microviscosity of puriﬁed salivarymucin,MUC5B, whichwas attributed
to the ability of EGCG to cause mucin sedimentation. Likewise, mucins
of gastric and duodenal origins, MUC5AC and MUC2, also showed in-
creased microviscosity upon treatment with EGCG. EGCG reportedly
caused the mucins to cross-link and undergo a sol–gel transition at
neutral pH (Georgiades, Pudney, Rogers, Thornton, & Waigh, 2014;
Georgiades, Pudney, Thornton, & Waigh, 2014). These results concur
with the earlier results of Zhao et al. (2012), which demonstrated the
multilayer binding of EGCG to gastric mucin dominantly due to hydro-
gen bonding and hydrophobic interaction of EGCG to the hydrophobic
domains of the mucin macromolecule. Unfortunately, no other ﬂavo-
noid has been investigated in relation to their interaction with puriﬁed
GI mucins, to the best of our knowledge.
Furthermore, studies involving crude mucus obtained from intesti-
nal explants are currently lacking in the literature and thus provide an
opportunity for further investigation. In our previous study, we foundet al., 2015) and EGCG (unpublished data) on intestinal mucus (A.1 — G′ and G″, A.2 —
Fig. 3. Particle tracking microrheology of ex vivo porcine intestinal mucus treated with EGCG (unpublished data) and KG (100, 300, 500 μg/mL) (Gonzales et al., 2015. A —mean square
difference, B — diffusion coefﬁcient.
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(unpublished data), do not cause signiﬁcant changes in the
microrheology of ex vivo porcine intestinal mucus (Fig. 3). This shows
that mucus microviscosity is not altered by ﬂavonoids although mucin
aggregation and an increase in microviscosity were observed in
ﬂavonoid-treated puriﬁed mucin. This could be due to the fact that the
actual mucin concentration in crude mucus is lower than those used
in puriﬁed mucin studies, where cross-linking is more likely to occur
due to crowding. Although no signiﬁcant change in microviscosity is
observed in crude mucus, the results from puriﬁed mucins indicate
the interaction of ﬂavonoids with mucin, which could reduce ﬂavonoid
bioavailability. Therefore, not only does the GI mucus prevent the pas-
sage of hydrophobic compounds, it reduces ﬂavonoid bioavailability
via non-covalent interactions.
6. Diffusion of ﬂavonoids through intestinal mucus
Detailed diffusion studies of ﬂavonoids or ﬂavonoid complexes
through the GI mucus are missing from the literature. Previously, we
have reported the diffusion of ﬂavonoid glycosides isolated from cauli-
ﬂower waste through ex vivo porcine intestinal mucus using ﬂuores-
cence recovery after photobleaching (FRAP). In this study, ﬂavonoid
glycosides efﬁciently diffused through the ex vivo mucus at a rate that
was ﬁve times slower than the diffusion of a 1-nm particle in water
calculated using the Stokes–Einstein equation (Gonzales, et al., 2015).
The fast rate of diffusion could be due to the inability of kaempferol
glycosides to form non-covalent interactions with the surrounding
mucin, as supported by the PTM analysis previously discussed.
FRAPwas also earlier used to analyze the aggregation of cholesterol-
enriched vesicles in gallbladder mucin (Afdhal et al., 2004). Therefore,
this technique could be useful in ascertaining the effect of micellation
or different micellar components improving the bioavailability of ﬂavo-
noids. The diffusion of ﬂavonoid and/or ﬂavonoid complexes (micelles,
nanostructures) through intestinal mucus could be useful in developing
methods to deliver ﬂavonoids or other drugs to the brush border to im-
prove bioavailability. Also, this technique may be used as a screening
procedure prior to using rat/mouse models.
7. Conclusion
Mucus is a complex barrier whose role in ﬂavonoid absorption
remains largely unexplored. Although ﬂavonoid bioavailability has
been conventionally analyzed using Caco-2 cells, which favored the
absorption of hydrophobic aglycones, various in vivo studies have
shown that ﬂavonoid bioavailability is improved by improving its
aqueous solubility. However, the direct and mechanistic involvement
of the mucus layer has never been clearly described. We hypothesize
that the mucus layer acts as a selective barrier that also inﬂuences the
fate of ﬂavonoids during digestion and absorption. Glycosylated ﬂavo-
noids and ﬂavonoids in micelles and other soluble complexes are ableto penetrate through the mucus layer, while the hydrophobic aglycone
could not. These aglycones are then pushed to the large intestine, where
microbial metabolism takes place. Rhamnosides also require bacterial
metabolism due to the lack of rhamnosidases in the brush border. Al-
though ﬂavonoids do not affect either the macro- or microviscosity of
the mucus layer, studies using puriﬁed mucin have shown that ﬂavo-
noidsmay bind tomucin via non-covalent interactions, which therefore
restrict their penetration through themucus. The diffusion of ﬂavonoids
through themucus layer has been demonstrated using FRAP. This tech-
nique could serve as a goodmethod in aid of developing better delivery
systems for ﬂavonoids and other drugs to improve their bioavailability.
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